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Abstract Multiple forms of phosphatidylinositol are
generated by differential phosphorylation of the inositol
headgroup. These phosphoinositides, specifically
PI(4,5)P2, have been implicated asmodulators in a variety
of transport processes. The data indicate that phosphoi-
nositides can modulate transporters directly or via the
activation of down-stream signaling components. The
phosphoinositide pathway has been linked to changes in
transporter kinetics, intracellular signaling, membrane
targeting andmembrane stability.Recent results obtained
for several of the well-characterized transport systems
suggest the need to reassess the role of PI(4,5)P2 and
question whether lower abundance forms of the phos-
phoinositides, notably PI(3,4,5)P3 (PIP3) and PI(3,4)P2,
are the pertinent transport regulators. In contrast to
PI(4,5)P2, these latter forms represent a dynamic, regu-
lated pool, the characteristics of which are more com-
patible with the nature of signaling intermediates. A
recently described, novel transepithelial signaling path-
way has been demonstrated for PIP3 in which a signal
initiated on the basolateralmembrane is transduced to the
apical membrane entirely within the planar face of the
inner leaflet of the plasmamembrane. The new paradigms
emerging from recent studies may be widely applicable to
transporter regulation in other cell types and are partic-
ularly relevant for signaling in polarized cells.
Phosphatidylinositol—a multifunctional substrate
Phosphatidylinositol is a low abundance membrane lipid
that serves as a precursor for several signaling pathways.
Research that culminated in the 1980s elucidated a
transduction pathway whereby specific cleavage of the
phosphatidylinositol head group produced soluble (ino-
sitol phosphates) as well as membrane-bound (diacylgly-
cerols) intermediates [3, 8].While this pathway is initiated
at the plasma membrane, typically by extracellular stim-
uli, the products of the enzymatic cleavage enable the
signal to be communicated to intracellular organelles,
most often the endoplasmic reticulum, where the release
of Ca2+ propagates and potentiates the stimulus.
More recently, a separate signal transduction mech-
anism, also originating with a modification of the
phosphatidylinositol headgroup, has been elucidated.
This mechanism, which has come to be described as the
phosphoinositide (PI) pathway, originates with the
enzymatic modification of the inositol headgroup by
phosphorylation resulting in multiply phosphorylated
forms of the lipid. In contrast to the previously men-
tioned pathway, this signal transduction mechanism is
envisioned as being propagated by the intact lipid rather
than by cleavage products. It is the latter pathway that is
the topic of this review. However, it is important to
point out that the two pathways need not be mutually
exclusive—it is clear that they often co-exist in the same
cells and utilize the same initial substrate. Thus, positive
and negative effectors that change the level of the sub-
strate phospholipid have the potential to modulate ei-
ther pathway.
Modification of the phosphatidylinositol head group
In the intact phosphatidylinositol lipid, the myo-inositol
head group can be enzymatically phosphorylated at
three positions—3, 4, and 5—giving rise to mono-, bis-,
and tris-phosphoinositides. Of the various possible
combinations and permutations, three relatively well-
studied forms have been identified as possible signaling
intermediates. These are the bis-phosphoinositides,
PI(3,4)P2 and PI(4,5)P2, and the tris-phosphoinositide,
PI(3,4,5)P3 (PIP3). The enzymatic interconversions be-
tween these three forms are illustrated in Fig. 1.
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Phosphatidylinositols (PI) represent less than 5% of
the membrane phospholipid pool [27]. Within this
phospholipid class, the various phosphorylated forms
differ in relative amounts in a predictable manner in
most cell types. Where the PI lipids have been isolated
and quantitated, PI(4,5)P2 has been found to comprise a
large, relatively static pool, whereas PI(3,4)P2 and PIP3
are low abundance and dynamic, showing rapid changes
in response to external stimuli. However, even in stim-
ulated cells, PIP3 and PI(3,4)P2 represent only a small
fraction of the total PI pool [6, 20, 27, 34, 37]. These
characteristics implicate the latter two phospholipids as
likely candidates for key players in signal transduction
pathways.
Dynamic changes in the abundance of PIP3 and
PI(3,4)P2 are the result of specific kinases and phos-
phatases. Of these, phosphoinositide 3-kinase (PI 3-ki-
nase) is the best characterized, in part because of the
availability of specific non-toxic inhibitors that can be
used in live cells. Wortmannin, a fungal metabolite,
irreversibly blocks PI3-kinase activity [30], whereas
LY294002 is a completely reversible inhibitor [44].
The enzymes responsible for the turnover of PIP3
have been characterized more recently. PTEN (phos-
phatase and tensin homologue), the converse of PI3-ki-
nase, removes the 3 position phosphate producing
PI(4,5)P2 [10, 12]. PTEN is a tumor suppressor which
has been found to be mutated or deleted in a variety of
tumors [11, 24]. The tumorogenic properties that result
from PIP3 accumulation have been ascribed to the kin-
ases activated downstream of PIP3 which are involved in
cell growth and survival [11, 24].
The SHIP (SH2-containing inositol 5’-phosphatase)
proteins are a family of enzymes initially identified in
blood cells. These phosphatases remove the 5’ phosphate
from the respective PI forms, thereby resulting in
heightened PI(3,4)P2 production. SHIP knockout mice
show myeloproliferation and growth factor hyper-
responsiveness [35], whereas SHIP 2 knockout mice
show increased sensitivity to insulin [36].
The physiological consequences resulting from a lack
of these enzymes underscores the importance of the low
abundance lipid products. Thus, despite their minute
quantities, PIP3 and PI(3,4)P2 are important in cellular
regulation.
PI pathway—building a scaffold
The PIP2s and PIP3 are multifunctional protein binding
entities capable of interacting with a variety of sub-
strates. In this regard, they can be envisioned as the
nucleus of a signaling scaffold that recruits cytosolic
signaling intermediates to the cell membrane [10, 12, 37].
Lipid binding pleckstrin homology (PH) domains in
proteins show specificity in their affinity for PI(4,5)P2,
PI(3,4)P2 or PIP3 [31, 32]. Therefore, the production of
particular phosphorylated PIs can serve as targeting sites
for signaling pathway intermediates. For example, the
formation of PIP3 and/or PI(3,4)P2 by PI3-kinase, re-
cruits soluble proteins such as protein kinase B (PKB)
and serum glucocorticoid kinase (Sgk) to the membrane
where they are activated and participate in downstream
signaling events [38]. The kinase cascades set in motion
by the formation of PIP3 have been extensively reviewed
[10, 12, 37].
Phosphoinositides can also bind to Src homology 2
(SH2) domains, including that of the p85a subunit of
PI3-kinase [14]. The ability of phosphoinositides to bind
SH2 domains is not as well delineated but may play a
crucial role in phosphotyrosine-dependent protein
recruitment.
PI3-kinases are a family of homologous proteins
usually consisting of a regulatory subunit and a catalytic
subunit. The best characterized are the class 1a PI3-
kinases, composed of an 85-kDa regulatory subunit and
110-kDa catalytic subunit. This is the type of PI3-kinase
that is recruited to the plasma membrane in response to
insulin receptor activation and the production of the
tyrosine-phosphorylated insulin-receptor substrate
(IRS). There are, of course, other signals that will recruit
PI3-kinases to the membrane. Predominately these
consist of cell surface receptors that, like insulin, can
activate PI3-kinase directly or through adaptor proteins
including the small GTP-binding proteins [37, 47].
Shepard and colleagues have suggested that the PI3-
kinases serve as part of a larger scaffolding complex via
the SH3 binding sites on the regulatory subunit [37].
Since this protein complex is recruited to the membrane,
one can now consider the possibility of a rather large
signaling complex, the strength and size of which is
dependent on the number and affinity of the multiple
binding partners.
PI lipids as modulators of transport proteins—regulation
of exocytosis and endocytosis
One of the most widely studied roles of the PI family of
lipids is the regulation of transport proteins. Demon-
strated and hypothetical mechanisms include direct
modulation of channel activity, alterations in channel
membrane targeting and the formation of scaffolds
which can recruit effectors as well as cytoskeletal ele-
ments. Interestingly, differentially phosphorylated forms
of the phosphoinositides may regulate the same trans-
port processes with different temporal phases.
The quantity of plasma membrane-expressed trans-
porters represents a delicate balance between exocytic
and endocytic events and both are regulated indepen-
Fig. 1 Formation of low-abundance lipid signaling intermediates,
PIP3 and PI(3,4)P2 from PI(4,5)P2. PI3-kinase phosphatidylinositol
3-kinase; PTEN phosphatase and tensin homologue; SHIP SH2-
containing inositol 5’-phosphatase
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dently. The prototypic example of phosphoinositide
modulation of a transporter is the insulin mediated
regulation of the glucose transporter, GLUT 4, in vari-
ous tissues. PI(4,5)P2 has well documented effects on
actin polymerization and changes in PI(4,5)P2 metabo-
lism have been shown to affect the endocytic recycling
pathway for GLUT4 resulting in a longer residence time
for the transporter in the plasma membrane [22]. On the
exocytic side of the recycling pathway, PIP3 is necessary
and sufficient for the insertion of GLUT4 into the
plasma membrane, however, PIP3-mediated insertion of
the transporter is not accompanied by an increase in
glucose uptake, suggesting the need for an additional,
unknown step in the activation pathway [41]. Concur-
rent with these changes, the PI pathway also activates a
number of downstream serine/threonine kinases such as
PKB (also called Akt) which are also intimately involved
in the regulation of GLUT4 trafficking and activity [1].
PI regulation of ion transport proteins
With regard to the modulation of ion transporters, the
most abundant member of the PI lipids, PI(4,5)P2 is the
favored regulator [20]. PI(4,5)P2 may be necessary for
functional maintenance of ion channel activity in a
manner analogous to the increased residency time of
GLUT 4 in the plasma membrane. PI(4,5)P2 has also
been postulated to form a link between the cytoskeleton
and the plasma membrane [21, 32]. An intact cytoskel-
eton is necessary for the function of some ion channels
and, therefore, represents a further level of potential
control. In addition, PI(4,5)P2 has been demonstrated to
reside at least partially in lipid rafts from which lateral
diffusion is restricted [27]. In this regard, the ‘‘raft’’
could be envisioned as a confined area where specific
intermediates are assembled. Finally, PI(4,5)P2 has re-
cently been shown to immobilize the inactivation do-
main of the delayed rectifier, voltage gated K+ channel
thereby converting it into an A-type K+ channel [29].
Is PI(4,5)P2 the lipid that regulates the majority of the
PI-sensitive ion channels as is rather widely accepted?
Upon careful consideration, PI(4,5)P2 is not, a priori,
the most logical candidate as a signal transduction
intermediate or as a mediator that would regulate
channel activity acutely in response to a stimulatory
agent. The static nature of the PI(4,5)P2 pool is not
compatible with the usual characteristics of signaling
intermediates. The literature also contains cautionary
indications against uniformly assuming PI(4,5)P2 is the
pivotal regulator.
The elucidation of the patch clamp technique for
studying transport through ion channels has afforded
researchers with the unique ability to study the regula-
tion and kinetics of these proteins at a single channel
level [28]. Channels can be studied in their native envi-
ronment, placed in an artificial lipid bilayer, or studied
in a heterologous expression system. In addition, the
formation of inside-out patches allows the investigator
to alter the composition of the fluid bathing the cyto-
plasmic face of the membrane in order to determine the
effect of various intracellular mediators.
Using the technique of patch clamp, PI lipids have
been perfused onto the cytoplasmic face of patches
formed from various types of cells and the effect on a
number of different channels has been documented. In
many cases, PI(4,5)P2 appears to directly modulate
channels contained in excised patches [reviewed in 20].
For example, ATP-sensitive K+ channels (KATP) pres-
ent in excised membrane patches from both native and
heterologously expressing cells were found to be acti-
vated by PI(4,5)P2 when the lipid was applied to the
cytosolic face [2, 19, 38]. Following these experiments, it
was assumed for several years that PI(4,5)P2 was the
pertinent channel activator. However, an elegant series
of studies by Harvey and co-workers have subsequently
demonstrated that both PI(4,5)P2 and PIP3 can activate
the channel [17, 18] Furthermore, the effect of PI(4,5)P2
is sensitive to LY294002 and wortmannin suggesting
that the formation of PIP3 is required for channel
function. These studies indicate that the excised patches
contain the PI3-kinase necessary to convert PI(4,5)P2 to
PIP3 and that the latter is most likely the pivotal regu-
lator. Is this an isolated finding or is it likely that
PI(4,5)P2 is not the key PI in the regulation of other
transporters?
The epithelial sodium channel, ENaC, has also been
shown to be regulated by PIs. The evolution of the
understanding of which phosphoinositides are key in the
modulation of ENaC is, in some ways, similar to that of
KATP. However, in the case of ENaC, PI lipids may
exert a bewildering array of effects on the Na+ transport
processes by affecting both acute and chronic ENaC
channel activity.
The multiplicity of effects of PI lipids on ENaC—questions
and controversies
Regulation of ENaC by phosphoinositides has been
examined from a functional standpoint in confluent high
resistance epithelia, at a single channel level, in heter-
ologous systems as well as in cells natively expressing the
channel. The techniques include electrophysiological
assays (whole tissue and patch clamp), biochemical
quantitation, and visualization of lipid production in
live, responsive cells.
The apparent controversies that emerge from a
compilation of these studies are: (1) a discrepancy as to
the nature of the key phosphoinositides which regulate
the channel, and (2) the mode of action of the lipid in
regulating the channel, often expressed as a stimulation
of ENaC insertion into the apical membrane versus a
change in the kinetic parameters of membrane-resident
channels.
The first controversial issue, that of which phospho-
inositide lipid functionally interacts with ENaC, may be
analogous to the apparent discrepancies reported for
77
regulation of the KATP channel. We will review some of
the findings below. The second controversy, the question
of whether the phosphoinositides regulate ENaC traf-
ficking or channel kinetics, may not be a controversy at
all—in fact, PIs may regulate channel exocytosis,
endocytosis and open probability albeit with different
time frames.
Initial studies indicating PI regulation of ENaC arose
from the observation that LY294002, a reversible
inhibitor of PI3-kinase, blocked insulin-stimulated Na+
transport in the A6 cell line, a well-characterized model
of the principal cells of the distal nephron [34]. Within
4 min, insulin causes a measurable increase in transepi-
thelial Na+ flux in intact monolayers [9, 34]. The na-
triferic (Na+ retaining) effect is preceded by a rapid
(1 min) increase in PIP3 in the cells. LY294002 blocked
the formation of the PIP3 as well as the insulin-induced
Na+ transport. Thus, the correlation between function
and biochemistry suggests that PIP3 may be a key reg-
ulator of ENaC-mediated Na+ transport.
In addition to cell surface receptors like insulin, the
PI pathway can also be activated by steroid hormones in
absorptive epithelial cells. For example, aldosterone
causes an increase in the production of PIP3 in A6 cells.
Consistent with the long-term, protein synthesis depen-
dent effects of the steroid hormone, the increase in PIP3
formation requires 20–60 min to reach a measurable
level. This is in agreement with the increase in transcel-
lular Na+ flux which begins within 45–60 min after
hormone addition, also in a protein synthesis dependent
fashion. Both the production of PIP3 and the functional
effects of aldosterone in this cell type are blocked by
LY294002 [6].
Interestingly, aldosterone also causes an increase in
the synthesis of Sgk—a downstream kinase recruited to
the membrane and activated in response to increased
PI3-kinase activity [13, 26]. Sgk phosphorylates and
inactivates NEDD4, a ubiquitin ligase which is thought
to stimulate channel endocytosis and degradation via
ubiquitination of ENaC [39, 40]. Thus, aldosterone has
at least two effects on the PI pathway—the formation of
PIP3 which may have immediate effects on the channel,
and the increased synthesis of Sgk which is known to
function in the regulation of channel endocytosis after
activation by the PI3-kinase pathway.
The results obtained in the intact cell studies are in
contrast to patch clamp studies also performed in the A6
cell line. Yue et al. found an increase in NPo (N denotes
the number of channels in the membrane; Po represents
the open probability) in excised patches perfused with
30 lM PI(4,5)P2 in the presence of 100 lM GTP or
10 nM aGi-3 [47]. Curiously, neither PIP3 nor PI(3,4)P2
were effective in increasing activity even in the presence
of GTP.
In a simultaneous publication, Ma et al. found that
either 5 lM PI(4,5)P2 or PIP3 prevented ENaC channel
rundown (loss of activity) in excised patches from A6
cells. Since phosphatidylserine was also effective in pre-
venting channel rundown, the authors suggested that the
action was mediated mainly by anionic lipids [23]. In
contrast to the Yue study, these effects were not
dependent on GTP.
The differences between the findings of the Yue and
Ma studies and those performed in intact A6 cells re-
main unexplained—particularly the discrepancies be-
tween the requirement for GTP and the structure of the
PI which modulates channel activity. It is important to
note that both of the patch clamp studies were per-
formed on A6 cells that had been chronically treated
with aldosterone. Based on the previous studies in intact
A6 cells, aldosterone causes the activation of PI3-kinase
[6]. Activation of this enzyme is associated with a
translocation to the plasma membrane. If the cells had
been chronically treated with the steroid hormone, it is
likely that a substantial amount of PI3-kinase may have
been associated with the plasma membrane and, there-
fore, could have been part of the patch used to examine
ENaC activity.
The requirement for GTP in the Yue study is
intriguing particularly given the finding that the effects
of insulin and aldosterone are additive in the A6 cell line
[5, 33]. It is somewhat enigmatic that two hormones
which stimulate the same intracellular pathway could
have additive effects. The patch clamp finding may
provide some clues to this puzzle. Several types of PI3-
kinases are found in cells. Class 1b PI3-kinases are G-
protein regulated while class 1a are independent of G-
proteins but are stimulated in response to insulin [37].
Thus, the formation of PIP3 via two different mecha-
nisms could explain the additive functional effects of the
two hormones, particularly if a step at or before the
formation of PIP3 were rate limiting.
Tong et al. also used patch clamp to examine the
effects of the PI lipids on ENaC in Chinese hamster
ovary (CHO) cells heterologously expressing the Na+
channel [42]. In the CHO cells, co-expression of ENaC
and constitutively active PI3-kinase increased ENaC-
specific inward currents. When applied to an inside-out
patch containing ENaC, PI(3,4)P2 and PIP3 caused in-
creases in the open probability, Po. This effect was not
dependent on GTP. The authors concluded that the
products of PI3-kinase can regulate the channel directly.
Recently Markadieu and colleagues examined the
effects of phosphoinositide lipids in intact A6 cells by
delivering the physiologically relevant long carbon chain
derivatives to the native cells via histone carriers [25]. It
is important to note that, unlike the patch clamp studies,
the A6 cells were not chronically treated with aldoste-
rone. Within 60 min of complex addition to the apical
membrane, PIP3 and PI(3,4)P2 increased transepithelial
Na+ transport while PI(4,5)P2 was completely ineffec-
tive. Expression of PTEN in excess over endogenous
levels, decreased both insulin-stimulated and PIP3-
stimulated Na+ transport. Since PTEN decreases the
amount of PIP3 in cells (Fig. 1), simultaneously adding
to the PI(4,5)P2 pool, these findings argue against a
stimulatory effect of PI(4,5)P2 in the intact A6 cells. The
authors also demonstrated that the p85 regulatory
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subunit of PI3-kinase was recruited to a tyrosine-phos-
phorylated complex (presumably containing the insulin-
receptor substrate) within minutes after insulin stimu-
lation. As expected, PTEN over-expression did not af-
fect this recruitment but did decrease the downstream
activation of PKB in the cells [25]. These results indicate
that the initial steps of the PI pathway proceed normally
in the transfected cells but decreases in cellular PIP3
inhibit downstream portions of the pathway resulting in
decreased insulin-stimulated Na+ transport.
Thus, a consensus of the studies in the A6 cells seems
to indicate that the products of PI3-kinase can regulate
ENaC-mediated Na+ transport acutely, which is con-
sistent with insulin’s immediate action in this model of
the principal cell type. Long-term regulation of the
channel, consistent with aldosterone’s natriferic effects,
may be mediated by a slower, protein synthesis depen-
dent formation of PIP3 and/or by activation of down-
stream elements of the pathway such as Sgk. Is this the
whole story or do the phosphoinositide lipids have ef-
fects on channel function other than increasing open
probability and inhibiting channel turnover via endo-
cytosis?
Blocker induced noise analysis experiments have been
performed on confluent monolayers of A6 cells stimu-
lated with both insulin and aldosterone [5, 8]. Noise
analysis is a technique that can independently measure
NT (channel density) and Po in a non-invasive manner.
These studies found that both insulin and aldosterone
increase the density of active ENaC channels in the
apical membrane with no increase in Po. Inhibition of
PI3-kinase with LY294002 reduces the number of open,
functional channels in the membrane. These studies
indicate that the formation of PIP3 may also be a factor
needed for channel insertion.
PIP3 as a transcellular transduction element:
a novel role for lipids in polarized cells
In addition to the functions summarized above, we have
recently elucidated another, rather unique role of
PIP3—that of the element in the pathway that conveys
the insulin signal from its origin on the basolateral
membrane to the final effectors on the apical membrane
(Fig. 2). Insulin binding to its receptor on the basolat-
eral membrane recruits PI3-kinase to the basolateral
membrane resulting in the production PIP3 [8]. Lipids,
such as PIP3, formed in the inner leaflet of the bilayer
can cross the tight junction of polarized epithelial cells
[15, 43]. This is a property not shared by integral
membrane proteins, confined to either the basolateral or
apical membrane by their inability to cross the junc-
tional complex. In this regard, lipids of the inner leaflet
are uniquely positioned to act as signal transducers in
polarized cells. However, until recently there was scant
evidence that intact lipids played a role in signal trans-
duction. Clearly, such a function requires the formation
of a low-abundance molecule whose synthesis and deg-
radation are precisely controlled—a molecule such as
PIP3.
An A6 cell model expressing low, physiologically
relevant levels of ENaC-GFP subunits has been pro-
duced and used to examine the natriferic effects of
insulin [7, 8]. Insulin stimulates the rapid recruitment of
ENaC from a diffuse intracellular localization and
stimulates its insertion into the apical membrane in a
PI3-kinase-dependent manner [8, 9]. The route followed
by the ENaC is somewhat atypical in that the channel
appears to move first to the area of the lateral membrane
where a co-localization with PI3-kinase is observed. This
association is not preserved as ENaC crosses the tight
junction and inserts into the apical membrane. Inhibi-
tion of PI3-kinase activity by LY294002 does not inhibit
the co-localization but does alter the intracellular site of
the interaction. In the presence of the inhibitor, the
ENaC-PI3-kinase complex is not found along the lateral
membrane but, rather, is present in a diffuse intracellular
dispersion [8].
The production and localization of PIP3 was exam-
ined in the A6 cell model. These recent studies used
confocal microscopy with rapid image acquisition to
visualize live cells in three dimensions. The live-cell
studies confirmed the previous studies (done in fixed
cellular monolayers) showing that ENaC is inserted into
the apical membrane in response to insulin [9]. In
addition, the most recent studies also confirm that
ENaC is first recruited to the lateral membrane but ex-
tend the previous experiments to show that the channel
does not enter the lateral membrane but seems to track
along the cell periphery before entering the apical
membrane.
To follow the route of the PIP3 taken after insulin
stimulation, cells were transiently transfected with the
PIP3 biosensor probe, EGFP-PH/Grp which specifically
binds the tris-phosphate form of phosphatidylinositol [9,
46]. Using this probe, it is possible to track the pro-
duction and movement of the lipid in real time. In re-
sponse to insulin, PIP3 is formed in the basolateral
membrane, diffuses along the lateral membrane, crossing
the tight junction and entering the apical membrane.
ENaC also enters the apical membrane with a similar
rapid time-course to that of PIP3 [9].
Many questions are raised by these studies. What
effectors are responsible for the recruitment and tracking
of ENaC along the lateral membrane? What are the
specific subcellular environmental conditions that enable
ENaC to track along the inner leaflet of the basolateral
membrane but to be inserted in the apical membrane?
The reader can, no doubt, envision many other issues
that remain unsolved. However, this unique signaling
pathway has many satisfying aspects. It is difficult to
imagine how the communication of a basolateral signal
can be delivered to the apical membrane by diffusion of
intracellular signaling components across the entire 3-
dimensional volume of the cell. This is particularly dif-
ficult to comprehend when many of the components of
the pathway are found to be associated with cellular
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membranes. Diffusion within the cytosol of the cell is
also hard to regulate, especially if the intermediates
modulate multiple cellular processes. Diffusion within
the plane of the membrane, specifically the inner leaflet,
provides for interaction with cytosolic elements but
confines the signal to a more manageable planar surface
and allows for the very rapid diffusional transit of a
small quantity of signal.
The elucidation of the membrane de-limited pathway
was made possible by several recent advances including
the production of specific biosensor probes and the
availability of confocal microscopes capable of rapid
imaging of live cells. Perhaps the application of these
techniques to other cellular systems will indicate that
this novel signaling pathway is not confined to ENaC
but is a component of multiple types of polarized cell
signaling.
Summary
The PI pathway is an integral part of the regulation of
many different transport proteins. The role of the lower
abundance members of this class of phospholipids re-
mains largely unappreciated because of the difficulty in
detecting and quantitating the very low quantities found
Fig. 2 Model of PIP3 transepithelial signal transduction. Insulin
binds to its receptor on the basolateral membrane activating
receptor autophosphorylation which leads to the subsequent
phosphorylation of the insulin receptor substrate (IRS). Phosphor-
ylated IRS stimulates the activation of PI3-kinase and its
translocation to the membrane. PI3-kinase catalyzes the formation
of PIP3 in the inner leaflet of the plasma membrane and this lipid
diffuses within the plane of the membrane, crossing the tight
junction to enter the apical membrane. Experimental results show
that immediately after insulin stimulation, the epithelial Na+
channel (ENaC) colocalizes with PI3-kinase along the lateral
membrane. The confocal methods used to characterize this
colocalization do not allow a determination of whether ENaC
and PI3-kinase are simply in close proximity or whether they
physically interact. The colocalization is not seen when ENaC
enters the apical membrane. The diffusion of PIP3 into the apical
membrane, appears to create a favorable environment for the
insertion of ENaC
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in both quiescent and stimulated cells. However, with
the advent of specific inhibitors and sensitive bioprobes
comes a new appreciation for the full range of potential
mediators which can result from modification of phos-
phatidylinositol.
The formation of several different effector molecules
raises the possibility of modulating multiple steps in a
biochemical pathway. Taking as an example the amilo-
ride-sensitive Na+ transporter, ENaC, where the path-
way has been studied both functionally and
biochemically, it is clear that there are, indeed, multiple
levels of regulation. Transepithelial Na+ transport rep-
resents a beautifully orchestrated system in which com-
ponents of the PI pathway have effects on channel
insertion, change in open probability and membrane
stabilization all initiated by the same signal(s) and all
controlled as separate entities within different time-
frames. This provides not only failsafe mechanisms but
also precisely regulated control of ion transport and
integration with multiple hormonal signals. As our
knowledge of the nuances of the PI pathway interme-
diates evolves, it is likely that similar complexities will be
elucidated in the regulation of other transport proteins
in a variety of cell types.
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